A single-dose, open-label study of TX000045 in patients with CpcPH or IpcPH and HFpEF.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508969-32-00

Acronym

TX000045-002

Enrollment

Registered

2024-04-04

Start date

2024-07-08

Completion date

2025-09-02

Last updated

2025-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Combined postcapillary and precapillary pulmonary hypertension / Isolated postcapillary pulmonary hypertension

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026